News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
11,444 Results
Type
Article (906)
Press Release (10538)
Section
Business (3044)
Career Advice (186)
Deals (593)
Drug Delivery (1)
Drug Development (1141)
Employer Resources (8)
FDA (273)
Job Trends (276)
News (5127)
Policy (423)
Tag
Academia (80)
Accelerated approval (1)
Alliances (693)
ALS (1)
Alzheimer's disease (104)
Antibody-drug conjugate (ADC) (1)
Approvals (288)
Artificial intelligence (10)
Autoimmune disease (2)
Automation (1)
Bankruptcy (3)
Best Places to Work (204)
Biosimilars (3)
Breast cancer (3)
Cancer (39)
Cardiovascular disease (3)
Career advice (155)
CAR-T (4)
Cell therapy (4)
Clinical research (982)
Collaboration (19)
Compensation (1)
COVID-19 (28)
C-suite (19)
Cystic fibrosis (3)
Data (98)
Depression (1)
Diabetes (6)
Diagnostics (119)
Digital health (1)
Diversity, equity & inclusion (4)
Drug discovery (3)
Drug pricing (1)
Earnings (1110)
Editorial (2)
Employer branding (1)
Employer resources (7)
Events (1686)
Executive appointments (20)
FDA (330)
Frontotemporal dementia (2)
Funding (21)
Gene editing (1)
Generative AI (2)
Gene therapy (9)
GLP-1 (14)
Government (61)
Guidances (6)
Healthcare (364)
Huntington's disease (1)
Immunology and inflammation (3)
Immuno-oncology (2)
Indications (1)
Infectious disease (28)
Inflammatory bowel disease (4)
Intellectual property (4)
Interviews (38)
IPO (245)
Job creations (73)
Job search strategy (140)
JPM (1)
Labor market (2)
Layoffs (3)
Leadership (4)
Legal (118)
Liver cancer (1)
Lung cancer (8)
Lymphoma (5)
Machine learning (1)
Management (1)
Manufacturing (11)
MASH (6)
Medical device (543)
Medtech (543)
Mergers & acquisitions (368)
Metabolic disorders (18)
Multiple sclerosis (1)
Neurodegenerative disease (24)
Neuropsychiatric disorders (1)
Neuroscience (162)
NextGen: Class of 2026 (206)
Non-profit (88)
Obesity (4)
Opinion (9)
Ovarian cancer (5)
Parkinson's disease (29)
Patents (6)
Patient recruitment (6)
People (1013)
Phase 1 (253)
Phase 2 (421)
Phase 3 (379)
Pipeline (60)
Policy (1)
Postmarket research (34)
Preclinical (105)
Prostate cancer (2)
Radiopharmaceuticals (3)
Rare diseases (13)
Real estate (142)
Recruiting (4)
Regulatory (304)
Reports (3)
Research institute (43)
Resumes & cover letters (17)
Rett syndrome (2)
Schizophrenia (11)
Series A (2)
Series B (2)
Special edition (1)
Spinal muscular atrophy (1)
Sponsored (5)
Startups (47)
Tariffs (1)
The Weekly (2)
Vaccines (7)
Venture capital (1)
Weight loss (8)
Women's health (4)
Worklife (2)
Date
Last 7 days (7)
Last 30 days (30)
Last 365 days (453)
2026 (45)
2025 (453)
2024 (490)
2023 (618)
2022 (964)
2021 (973)
2020 (886)
2019 (935)
2018 (729)
2017 (624)
2016 (570)
2015 (601)
2014 (460)
2013 (411)
2012 (416)
2011 (401)
2010 (346)
Location
Africa (28)
Alabama (1)
Arizona (8)
Asia (593)
Australia (193)
California (141)
Canada (34)
China (3)
Colorado (3)
Connecticut (8)
Delaware (3)
Europe (1452)
Florida (32)
Georgia (44)
Idaho (1)
Illinois (7)
Indiana (10)
Japan (4)
Maryland (45)
Massachusetts (73)
Michigan (3)
Missouri (13)
Nevada (2)
New Hampshire (1)
New Jersey (50)
New Mexico (1)
New York (104)
North Carolina (30)
Northern California (39)
Ohio (2)
Oregon (1)
Pennsylvania (18)
Rhode Island (4)
South America (34)
Southern California (84)
Tennessee (1)
Texas (30)
United States (639)
Virginia (3)
Washington State (22)
11,444 Results for "glass lewis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
April 30, 2025
·
1 min read
Press Releases
Resverlogix Appoints Bradley Glass to Board of Directors
November 19, 2025
·
1 min read
Press Releases
Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
February 5, 2026
·
7 min read
Press Releases
Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies
January 28, 2026
·
6 min read
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
After Emma Walmsley steps down as GSK CEO in January, Vertex Pharma’s Reshma Kewalramani will be the sole female CEO at a top-20 pharma company. Still, there are many prominent women in pharma that could someday break through again.
September 29, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies
January 6, 2026
·
8 min read
Genetown
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
Surface Oncology, Inc. announced that both Institutional Shareholder Services and Glass, Lewis & Co. have recommended Surface stockholders vote “FOR” the adoption of Surface’s merger agreement with Coherus BioSciences, Inc.
August 31, 2023
·
16 min read
Press Releases
CervoMed Announces Alignment with FDA on Registration Path for Neflamapimod in Dementia with Lewy Bodies
November 5, 2025
·
8 min read
Press Releases
Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules
September 10, 2025
·
5 min read
Press Releases
Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
December 3, 2025
·
7 min read
1 of 1,145
Next
